29Feb
Phases of Clinical Trials: Why and How?
Before being available in market for the public, any medical therapy needs to successfully go through the multiple phases of clinical trials. But why and…
Our blog
Tag: Clinical Trials
28Feb
How to Overcome Crucial Challenges in Clinical Data Management?
Ever since its inception in the 1920s, clinical data management has been a boon for the life sciences industry in determining the success of clinical…
22Feb
Clinical Trial Management System (CTMS): Everything You Need To Know
Efficiency is of paramount importance in clinical trials and CTMS serves as the backbone in ensuring it. With its unique set of features, a CTMS…
19Feb
Fundamentals of Understanding SDTM in Clinical Trials – Part II
The significance of SDTM in clinical trials is massive. It plays a key role in streamlining data management, ensuring regulatory compliance, and accelerating drug development.…
13Feb
Biggest Challenges in Oncology Clinical Trials
From patient recruitment to regulatory problems to complex trial designs, oncology clinical trials face a lot of challenges. Read about the 6 biggest obstacles in…
07Feb
Companies Leveraging the Power of Generative AI in Life Sciences
The fusion of GenAI is revolutionizing the clinical research industry. Many organizations are harnessing generative artificial intelligence to better their clinical processes and more. Read…
30Jan
Key Differences Between Small Molecule Drugs and Large Molecule Drugs
Small molecule drugs navigate cellular pathways with molecular finesse, often administered orally for user convenience. Contrastingly, large molecule drugs, demand meticulous biological scrutiny, opting for…
23Jan
5 Crucial FDA Decisions to Look Out for in 2024’s Quarter 1
FDA is anticipated to make some key decisions in the first quarter of 2024 with regards to drug approvals. Read about the 5 crucial decisions…
16Jan
10 Clinical Trials in 2024 that can Turn the Industry Tide
Organizations like Sanofi and Pfizer are venturing into uncharted territories with clinical trials in 2024. Sanofi's Gemini trials, examining tolebrutinib in multiple sclerosis, face challenges…
